Blockading PD-L1 with an antibody promoted helper T cell (Th) 1 cytokine–activated natural killer cells exhibiting antitumor functions [15], suggesting that PD-1/PD-L1 signaling has critical inhibitory roles in mediating innate and adaptive immunity in the tumor microenvironment. This evidence concerns the gene CD274 and neoplasm.